H. Oeney

Weekly vinorelbine (VIN) vs weekly docetaxel (DOC) for metastatic breast cancer failing anthracyclines. Planned interim analysis of a randomized trial.

M. Steder, H. Illiger, H. Deertz, 2004, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Weekly Vinorelbine versus Docetaxel for Metastatic Breast Cancer after Failing Anthracycline Treatment

S. Rotermund, M. Steder, J. Janssen, 2008, Oncology Research and Treatment.